Filter posts

BIO Convention Post-Con, Plus a Look Ahead

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. …

State of the Biotech Industry: Burrill's Biotech 2013 Report

To open his Super Session at the 2013 BIO International Convention, G. Steven Burrill, CEO …

Managed Entry Trumps Risk Sharing

Since 2000, pharmaceu-tical and biotech companies have engaged in agreements with government and private payers …

Ernst & Young's Beyond Borders: Matters of Evidence

Hundreds of attendees turned out to glean insights from findings outlined in Ernst & Young …

Results from the BIO Convention 2013 Meeting Analysis of Therapeutic In/Out Licensors

BIO’s results from the BIO 2013 Convention 1×1 meeting analysis conducted to identify trends and intentions …

Venture Capital Trends

With industry data and numbers, results are always a mixed bag, says David Thomas, BIO’s …

Finding Biotech in the Silicon Prairie

The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the …

BIO One-On-One Partnering Kicks Off!

Partnering kicked off this today at the Business Forum at the 2013 BIO International Convention, …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …

Crowdfunding Goes Viral

Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are …